Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00057941 Information provided by National Cancer Institute (NCI)

First Received: April 7, 2003 Last Updated: October 23, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)